170 related articles for article (PubMed ID: 15633158)
1. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Hayee BH; Harris AW
Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
[No Abstract] [Full Text] [Related]
2. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Ford AC
Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
[No Abstract] [Full Text] [Related]
3. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Reinisch W; Stange EF;
Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
[No Abstract] [Full Text] [Related]
5. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G
Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028
[TBL] [Abstract][Full Text] [Related]
7. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
Doherty GA; Miksad RA; Cheifetz AS; Moss AC
Inflamm Bowel Dis; 2012 Sep; 18(9):1608-16. PubMed ID: 21905173
[TBL] [Abstract][Full Text] [Related]
8. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.
Doherty G; Moss AC
Am J Gastroenterol; 2012 Mar; 107(3):487; author reply 487-8. PubMed ID: 22388032
[No Abstract] [Full Text] [Related]
9. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
Schwartz M; Regueiro M
Curr Gastroenterol Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21042888
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Karoui S; Kallel L; Boubaker J; Filali A
Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
[TBL] [Abstract][Full Text] [Related]
11. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH
Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027
[TBL] [Abstract][Full Text] [Related]
12. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
Ardizzone S; Bollani S; Manzionna G; Colombo E; Maconi G; Imbesi V; Bianchi Porro G
Ann Ital Chir; 2003; 74(6):621-5. PubMed ID: 15206802
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
[TBL] [Abstract][Full Text] [Related]
15. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
17. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
Sorrentino D; Paviotti A
Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
[No Abstract] [Full Text] [Related]
18. Conventional treatment of Crohn's disease: objectives and outcomes.
Rutgeerts PJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S2-8. PubMed ID: 11380039
[TBL] [Abstract][Full Text] [Related]
19. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
Sedano Muñoz R; Quera Pino R; Ibáñez Lazo P; Figueroa Corona C; Flores Pérez L
Gastroenterol Hepatol; 2019 May; 42(5):339-347. PubMed ID: 30954317
[TBL] [Abstract][Full Text] [Related]
20. [Postoperative recurrence of Crohn's disease, and its prevention].
Lakatos L; Lakatos PL
Orv Hetil; 2010 May; 151(21):870-7. PubMed ID: 20462847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
